Pionyr Immunotherapeutics is a private clinical-stage biotechnology company focused on developing first-in-class antibody therapeutics that enhance the body's anti-tumor immunity, particularly in the field of immuno-oncology
Pionyr Immunotherapeutics is a private clinical-stage biotechnology company focused on developing first-in-class antibody therapeutics that enhance the body's anti-tumor immunity, particularly in the field of immuno-oncology. The company utilizes novel target discovery and antibody generation technologies to create therapies that tune the tumor microenvironment.